This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Q2 FY27 vs Q2 FY26: revenue up 14.9%, profit after tax up 58.8%
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board-approved consolidated Q2 FY27: revenue Rs 636.19 crore, up 14.9% from Rs 553.72 crore in Q2 FY26; profit after tax Rs 14.56 crore, up 58.8% from Rs 9.17 crore. Standalone Q2: revenue Rs 345.38 crore; profit Rs 1.65 crore. H1 FY27 consolidated: revenue Rs 1,298.61 crore; profit Rs 59.99 crore; operating cash flow minus Rs 42.87 crore. Borrowings: 0.68 times equity; Q2 had another auditor than Q1 FY27. Promoter-group sale: Rs 0.46 crore.
Profit growth supports sentiment, but negative operating cash flow and a mid-year auditor change are concerns; review found no material misstatement.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹636.2 Cr | ₹553.9 Cr | +14.9% |
| Operating profit | ₹23.78 Cr | ₹11.38 Cr | +109.0% |
| Profit after tax | ₹14.56 Cr | ₹9.17 Cr | +58.8% |
| EBITDA margin | 12.4% | 9.6% | +2.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.